Security key
98422T100
Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)
CUSIP: 98422T100
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 14,508,823
- Total 13F value
- $13,746,216
- Share change
- +2,037,654
- SEC-reported price per share
- $0.95
- Number of holders
- 31
- Value change
- +$1,785,264
- Number of buys
- 16
- Number of sells
- 12
- Shares outstanding
- 6,426,426
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
31
Top holders
10
XLO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Xilio Therapeutics, Inc. SEC filings
Xilio Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98422T100
Recent filing periods:
Ownership snapshot
Top reported holders of XLO - Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bain Capital Life Science...
Disclosed value leader
Bain Capital Life Science...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 44%
Showing 1-6 of 15 holder rows.
Quick read
Bain Capital Life Sciences Investors, LLC leads the comparable SEC ownership view at 44%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.
Comparable ownership
Top 5
Bain Capital Life Sciences Invest...
44%
FMR LLC
30%
TAKEDA PHARMACEUTICAL CO LTD
23%
RiverVest Venture Management LLC
22%
Rock Springs Capital Management LP
22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
Company · 10%+ Owner
|
44%
|
$3,029,846
2,805,413 shares
|
— | 31 Mar 2024 |
| FMR LLC |
13F
3/4/5
Company · Other*
|
30%
|
$2,060,285
1,907,671 shares
|
— | 31 Mar 2024 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
3/4/5
Company · 10%+ Owner
|
23%
|
$1,593,131
1,475,121 shares
|
— | 31 Mar 2024 |
| RiverVest Venture Management LLC |
13F
Company
|
22%
|
$1,556,790
1,441,444 shares
|
— | 31 Mar 2024 |
| Rock Springs Capital Management LP |
13F
3/4/5
Company · 10%+ Owner
|
22%
|
$1,556,020
1,440,759 shares
|
— | 31 Mar 2024 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
15%
|
$1,072,345
992,912 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
14,508,823
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
30
Q2 2024 holders
31
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend